Portal de Periódicos da CAPES

Effects of Diltiazem or Lisinopril on Massive Proteinuria Associated with Diabetes Mellitus

1990; American College of Physicians; Volume: 112; Issue: 9 Linguagem: Inglês

10.7326/0003-4819-112-9-707

1539-3704

George L. Bakris,

Renin-Angiotensin System Studies

Brief Reports1 May 1990Effects of Diltiazem or Lisinopril on Massive Proteinuria Associated with Diabetes MellitusGeorge L. Bakris, MDGeorge L. Bakris, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-112-9-707 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptRecent studies in hypertensive, diabetic rats have shown that angiotensin-converting enzyme inhibitors reduce urinary protein excretion and preserve renal function to a greater extent than other antihypertensive agents (1, 2). The effects of calcium channel antagonists on urinary protein excretion and renal hemodynamics vary (3, 4). The renal hemodynamic effects of diltiazem, however, have been shown to be similar to angiotensin-converting enzyme inhibitors (5, 6). We did a prospective crossover trial with diltiazem or lisinopril in eight diabetic, hypertensive patients with nephrotic-range proteinuria to compare the renal effects of these agents.Patients and MethodsEight noninsulin-dependent diabetic patients (three men...References1. AndersonRennkeGarciaBrenner SHDB. Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int. 1989;36:526-36. CrossrefMedlineGoogle Scholar2. ZatzDunnMeyerAndersonRennkeBrenner RBTSHB. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986;77:1925-30. CrossrefMedlineGoogle Scholar3. JacksonCubelaDebreviWhittyJohnston BRLMC. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat. J Cardiovasc Pharmacol. 1987;10(Suppl 10):5167-9. Google Scholar4. MimranInsuaRibsteinMonnierBringerMirouse AAJLJJ Contrasting effects of Captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. J Hypertens. 1988;6: 919-23. CrossrefMedlineGoogle Scholar5. IsshikiAmodeoMesserliPegramFrohlich TCFBE. Diltiazem maintains renal vasodilation without hyperfiltration in hypertension: studies in essential hypertensive man and spontaneously hypertensive rat Cardiovascular Drugs and Therapy. 1987;1:359-66. CrossrefMedlineGoogle Scholar6. AndersonClareyRileyTroy SLSJ. Acute infusion of calcium channel blockers reduces glomerular capillary pressure in rats with reduced renal mass [Abstract]. Kidney Int. 1988;33:370A. Google Scholar7. SunderrajanReamsBauer SGJ. Long-term renal effects of diltiazem in essential hypertension. Am Heart J. 1987;114:383-8. CrossrefMedlineGoogle Scholar8. GiorgiGiorgide Almeida BurdmannSilvaMarcoudes DMEHM. Effects of lisinopril on the renal plasma flow and renin-angiotensin-aldosterone system in patients with essential hypertension. J Hypertens. 1986;4(Suppl 5):5420-2. Google Scholar9. EisenbachLiewBoylanManzMuir GJJNP. Effect of angiotensin on the filtration of protein in the rat kidney: a micropuncture study. Kidney Int. 1975;8:80-7. CrossrefMedlineGoogle Scholar10. Heegde Jongvan der Hemde Zeeuw JPGD. Efficacy and variability of the antiproteinemic effect of ACE inhibition by lisinopril. Kidney Int. 1989;36:272-9. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: From the Ochsner Clinic, New Orleans, Louisiana. For current author address, see end of text. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByNondihydropyridine Calcium Channel Blockers for the Treatment of Proteinuria: A Review of the LiteratureCardiovascular Disease and Diabetic Kidney DiseaseTherapeutic Modalities in Diabetic Nephropathy: Standard and Emerging ApproachesTherapeutic Modalities in Diabetic Nephropathy: Future ApproachesDual therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus ratsJapan-Indonesia Collaborative Study of Imidapril on Antiproteinuric Effect in Hypertensive Patients with Chronic Kidney Disease (CKD)Effects of Calcium Channel Blockers on Proteinuria in Patients With Diabetic NephropathyAngiotensin receptor blockade in diabetic renal disease—Focus on candesartanChronic kidney disease (CKD) in the elderly – a geriatrician's perspectiveACE-inhibitor use and the long-term risk of renal failure in diabetesRenoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatmentBENEDICT in the treatment of hypertensionRenal Protection in Chronic Kidney DiseaseCalcium antagonistsNefroprotektivnyy effekt antigipertenzivnoy terapii: issledovanie IRISReferencesCALCIUM CHANNEL BLOCKERS IN THE PREVENTION OF END STAGE RENAL DISEASE: A REVIEWThe verapamil versus amlodipine in nondiabetic nephropathies treated with trandolapril (VVANNTT) studyComparative effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidneyAntiproteinuric effect of niceritrol, a nicotinic acid derivative, in chronic renal disease with hyperlipidemia: a randomized trialPharmacologic management of diabetic nephropathyThe choice of antihypertensive drugs in patients with diabetes: Angiotensin II and beyondEstrategias en el tratamiento de la hipertensión arterial para prevenir el desarrollo de insuficiencia renalRole of diltiazem in pregnant women with chronic renal diseaseEVIDENCE-BASED TREATMENT OF HYPERTENSION IN PATIENTS WITH TYPE 2 DIABETESSlowing the Progression of Renal Disease in Diabetic PatientsEffect of nitrendipine and nisoldipine on renal structure and function in long-term experimental diabetes in ratsCalcium channel blockers – the effect on renal changes in clinical and experimental diabetes: an overviewThe Irbesartan Type II Diabetic Nephropathy Trial: study design and baseline patient characteristicsAntihypertensive Treatment in NIDDM, with Special Reference to Abnormal AlbuminuriaLacidipine reduces high blood pressure and the target organ damage induced by high fructose diet in ratsEffect of the calcium channel blocker nitrendipine in normotensive and spontaneously hypertensive, diabetic rats on kidney morphology and urinary albumin excretionLacidipine Prevents the Hypertension and Renal and Cardiac Changes Induced by High-Fructose Diet in WKY RatsRenal disease and hypertension in non–insulin-dependent diabetes mellitusEffect of enalapril on urinary glycosaminoglycan, heparan sulphate and microalbuminuria in type II diabetic patientsAntihypertensive treatment of patients with proteinuric renal diseases: Risks or benefits of calcium channel blockers?Noninflammatory Vascular Disease of the KidneyPrevention of Progression of Renal DiseaseAntihypertensive Treatment in NIDDM, With Special Reference to Abnormal AlbuminuriaShor- and long-term effect of a calcium channel blocker, barnidipine, on renal hemodynamics in spontaneously hypertensive, diabetic ratsCalcium channel blocker therapy and retarding the progression of chronic renal diseaseEffect of the Calcium Channel Blocker Nilvadipine on Urinary Albumin Excretion in Hypertensive Microalbuminuric Patients with Non-Insulin-Dependent Diabetes MellitusPrevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapyDiversity of calcium antagonistsCan we further slow down the progression to end-stage renal disease in diabetic hypertensive patients?Therapeutic challenges in the obese diabetic patient with hypertensionHYPERTENSION IN DIABETES MELLITUSIndapamide Is as Effective as Captopril in the Control of Microalbuminuria in DiabetesComparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuriaComparative Study of the Effect of Ace Inhibitors and other Antihypertensive Agents on Proteinuria in Diabetic PatientsAntihypertensive Treatment in NIDDM, with Special Reference to Abnormal AlbuminuriaCalciumantagonisten bei NierenerkrankungenDiltiazem: Ten Years of Clinical Experience in the Treatment of HypertensionHypertension in Diabetic Patients: An Update of Interventional Studies to Preserve Renal FunctionSelected Aspects of ACE Inhibitor Therapy for Patients with Renal Disease: Impact on Proteinuria, Lipids and PotassiumAn Individualized Approach to the Hypertensive Patient with Renal Disease: Six Illustrative Case StudiesType II diabetic nephropathy in perspectiveNifedipine, but not verapamil, acutely elevates parathyroid hormone levels in premenopausal womenCalcium-Channel Entry Blocker Therapy for Hypertensive Patients with Concomitant Renal Impairment: A Focus on IsradipineLong-Term Treatment With Either Enalapril or Nitrendipine Stabilizes Albuminuria and Increases Glomerular Filtration Rate in Non- Insulin-Dependent Diabetic PatientsAngiotensin converting enzyme inhibitors and diabetic renal diseaseHypertension and Endstage Renal DiseaseThe paradox of the renin-angiotensin system in chronic renal diseaseAntihypertensive Treatment in NIDDM, with Special Reference to Abnormal AlbuminuriaLong-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuriaSystemic hypertension and the renin-angiotensin system in diabetic vascular complicationsAntihypertensive therapy with the calcium channel blocker isradipine: An appropriate choice for the diabetic patient with hypertensionDiabetic nephropathyPharmacokinetics and pharmacodynamics of benazepril hydrochloride in patients with major proteinuriaCalcium Antagonists and the Diabetic Hypertensive PatientNephroprotective Effects of Nitrendipine in Hypertensive Tune I and Type II Diabetic PatientsLong-term effects of antihypertensive regimens on renal hemodynamics and proteinuriaCaptopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.Effect of diltiazem on glomerular heparan sulfate and albuminuria in diabetic rats.Renal Effects of Antihypertensive Medications: An OverviewHypertension in diabetic nephropathy: Prevention and treatmentHave Rational Therapeutic Principles Emerged in Treating Hypertension in Chronic Renal Failure?Hemodynamic Alterations and Urinary Albumin Excretion in Patients With Essential HypertensionThe progression rate of chronic renal failure with hypertension and proteinuria can be slowed by treatment with angiotensin converting enzyme inhibitorsAngiotensin-Converting Enzyme Inhibitors in Diabetic NephropathyMaturity-onset diabetes and nephropathyRecognition and prevention of drug-induced acute renal failureA Comparison of Spirapril and Isradipine in Patients with Diabetic Nephropathy and HypertensionCalcium Antagonists and Renal ProtectionHypertension and DiabetesAbnormalities of systemic blood pressure in diabetes mellitusMicroalbuminuria in patients with essential hypertension: Effects of several antihypertensive drugsA Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Enalapril in Patients With Clinical Diabetic NephropathyFirst-line pharmacological treatment of hypertensionComparative effects of captopril versus nifedipine on proteinuria and renal function of type 2 diabetic patientsThe evolution of antihypertensive therapy: Current theoretical conditions and individualized treatment optionsHypertensive nephropathy: Is a more physiologic approach to blood pressure control an important concern for the preservation of renal function?Nephrotic syndrome in adultsHypertension, the endothelial cell, and the vascular complications of diabetes mellitus.Management of Hypertension in DiabetesDiabetes mellitus and hypertension.Nifedipine versus fosinopril in uninephrectomized diabetic ratsAngiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathyTreatment of arterial hypertension in diabetic humans: Importance of therapeutic selectionRisk for renal injury in diabetic hypertensive patientsAngiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients.The Ageing Kidney: Practical Considerations in the Management of the Elderly Patient with Renal DiseaseHypertension and the KidneyNitroprusside, Nitroglycerin, and Angiotensin-Converting Enzyme InhibitorsImpact of age, race, and obesity on hypertensive mechanisms and therapyComparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.Calcium-Channel Antagonists Reduce Renal Protein ExcretionRonald H. Lewis, MDThe Antiproteinuric Effect of Angiotensin-Converting-Enzyme Inhibitors in Human Renal DiseaseEffects of Different Calcium Antagonists on Proteinuria Associated with Diabetes MellitusBryan K. Demarie, MD, George L. Bakris, MD 1 May 1990Volume 112, Issue 9Page: 707-708KeywordsAngiotensin converting enzyme inhibitorCalcium channel blockerDiabetes mellitusEpidermal growth factorExcretionHemodynamicsNephrologyProteinsProteinuria Issue Published: 1 May 1990 PDF DownloadLoading ...